Public Policy: Where we've been…Where we need to go
نویسندگان
چکیده
منابع مشابه
An Australian Example of Translating Psychological Research into Practice and Policy: Where We are and Where We Need to Go
Research findings from psychological science have identified interventions that will benefit human health. However, these findings are not often incorporated into practice-based settings or used to inform policy, in part, due to methodological and contextual limitations. A strategic approach is required if we are to find a way to facilitate the translation of these findings into areas that will...
متن کاملAccess to Healthcare Interpreter Services: Where Are We and Where Do We Need to Go?
Due to international migration, health care professionals in Switzerland increasingly encounter language barriers in communication with their patients. In order to examine health professionals' attitudes and practices related to healthcare interpreting, we sent a self-administered questionnaire to heads of medical and nursing departments in public healthcare services in the canton of Basel-Stad...
متن کاملGlobal recognition of qualified toxicologic pathologists: where we are now and where we need to go.
Although there are a few national schemes for accreditation/certification of toxicologic pathologists (e.g., in Japan and the United Kingdom), a global recognition system for bench toxicologic pathologists is missing, as are universal standards defining their core competencies. This paper summarizes basic means regarding how proficiency in toxicologic pathology is acquired, provides an overview...
متن کاملVaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
In this review we discuss recent progress in the development, testing, and clinical evaluation of new vaccines against tuberculosis (TB). Over the last 20 years, tremendous progress has been made in TB vaccine research and development: from a pipeline virtually empty of new TB candidate vaccines in the early 1990s, to an era in which a dozen novel TB vaccine candidates have been and are being e...
متن کاملExperimental therapeutics in prostate cancer: where are we now and where do we need to go.
T he explosion of new therapeutics in metastatic castrate-resistant prostate cancer (mCRPC) is unprecedented, but much more work needs to be done before we are satisfied. Six phase III trials with an overall survival impact have now been reported (Table 1). Four of these trials were exclusively or predominantly in the mCRPC post-docetaxel space (MDV3100, abiraterone, radium and cabazitaxel). Th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ Supportive & Palliative Care
سال: 2012
ISSN: 2045-435X,2045-4368
DOI: 10.1136/bmjspcare-2012-000250.1